Journal of Vascular and Interventional Radiology
Volume 20, Issue 1 , Pages 9-16 , January 2009

Clinical Predictors of Transient Ischemic Attack, Stroke, or Death within 30 Days of Carotid Artery Stent Placement with Distal Balloon Protection

  • Yasuhiro Kawabata, MD

      Affiliations

    • Department of Neurosurgery, Hamamatsu Rosai Hospital, Shizuoka, Japan
    • ,
  • Nobuyuki Sakai, PhD, MD

      Affiliations

    • Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Japan
    • Corresponding Author InformationAddress correspondence to N.S., Department of Neurosurgery, Kobe City Medical Center General Hospital, 4-6 Minatojimanaka-machi, Chuo-ku, Kobe 650-0046, Japan
    • ,
  • Izumi Nagata, MD, PhD

      Affiliations

    • Department of Neurosurgery, Nagasaki University Hospital, Nagasaki, Japan
    • ,
  • Fumihiko Horikawa, MD

      Affiliations

    • Department of Neurosurgery, Hamamatsu Rosai Hospital, Shizuoka, Japan
    • ,
  • Hidenori Miyake, PhD, MD

      Affiliations

    • Department of Neurosurgery, Hamamatsu Rosai Hospital, Shizuoka, Japan
    • ,
  • Yasushi Ueno, PhD, MD

      Affiliations

    • Department of Neurosurgery, Hamamatsu Rosai Hospital, Shizuoka, Japan
    • Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Japan
    • ,
  • Haruhiko Kikuchi, MD, PhD

      Affiliations

    • Department of Neurosurgery, Kobe City Medical Center General Hospital, Kobe, Japan

Received 25 October 2007 ,Revised 5 October 2008 ,Accepted 6 October 2008.

References 

  1. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453
  2. ECST Collaborative Group. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379–1387
  3. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421–1428
  4. Halliday A, Mansfield A, Marro J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet. 2004;363:1491–1502
  5. US Food and Drug Administration. Summary of Safety and Effectiveness Data, Acculink Carotid Stent System and Rx Acculink Carotid Stent System, Guidant Corporation, PMA# P040012. http://www.fda.gov/cdrh/mda/docs/p040012.htmlAccessed August 30, 2004.
  6. US Food and Drug Administration. Summary of Safety and Effectiveness Data, Xact Carotid Stent System, Abbott Vascular Devices, PMA# P040038. http://www.fda.gov/cdrh/mda/docs/p040038.htmlAccessed September 6, 2005.
  7. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355:1660–1771
  8. Theiss W, Hermanek P, Mathias K, et al. Pro-CAS: a prospective registry of carotid angioplasty and stenting. Stroke. 2004;35:2134–2139
  9. White CJ, Lyer SS, Hopkins LN, et al. Carotid stenting with distal protection in high surgical risk patients: the BEACH trial 30 day results. Cathet Cardiovasc Intervent. 2006;67:503–512
  10. Brooks WH, McClure RR, Hones MR, et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol. 2001;38:1589–1595
  11. CaRESS Steering Committee. Carotid Revascularization using Endarterectomy or Stenting Systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg. 2005;42:213–219
  12. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501
  13. Bates ER, Babb JD, Casey DE, et al. ACCF/SCAI/SVMB/SIR/ASITN 2007 (Clinical expert consensus document on carotid stenting). J Am Coll Cardiol. 2007;49:126–170
  14. Parodi JC, La Mura R, Ferreira M, et al. Initial evaluation of carotid angioplasty and stenting with three different cerebral protection devices. J Vasc Surg. 2000;32:1127–1136
  15. Powell RJ, Allessi C, Nolan B, et al. Comparison of embolization protection device-specific technical difficulties during carotid artery stenting. J Vasc Surg. 2006;44:56–61
  16. Parodi JC, Schonholz C, Ferreira M, et al. “Seat Belt and Air Bag” technique for cerebral protection during carotid stenting. J Endovasc Ther. 2002;9:20–24
  17. Al-Mubarak N, Roubin GS, Vitek JJ, et al. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation. 1999;104:1999–2002
  18. Chaer R, Trocciola S, DeRubertis B, et al. Cerebral ischemia associated with GuardWire balloon occlusion balloon during carotid stenting: incidence and possible mechanisms. J Vasc Surg. 2006;43:946–952
  19. Henry M, Henry I, Klonaris C, et al. Benefits of cerebral protection during carotid stenting with the PercuSurge GuardWire system: midterm results. J Endovasc Ther. 2002;9:1–13
  20. Martin JB, Pache JC, Treggiri-Venzi M, et al. Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke. 2001;32:479–484
  21. Al-Mubarak N, Colombo A, Gaines PA, et al. Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol. 2002;39:841–846
  22. Macdonald S, McKevitt F, Venables GS, et al. Neurological outcomes after carotid stenting protected with the NeuroShield filter compared to unprotected stenting. J Endovasc Ther. 2002;9:777–785
  23. Kwon BJ, Han MH, Kang HS, et al. Protection filter-related events in extracranial carotid artery stenting: a single-center experience. J Endovasc Ther. 2006;13:711–722
  24. Safian RD, Bresnahan JF, Jaff MR, et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol. 2006;47:2384–2389
  25. Kasirajan K, Schneider PA, Kent KC. Filter devices for cerebral protection during carotid angioplasty and stenting. J Endovasc Ther. 2003;10:1039–1045
  26. Reimers B, Sievert H, Schuler GC, et al. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther. 2005;12:156–165
  27. Asakura F, Kawaguchi K, Sakaida H, et al. Diffusion-weighted MR imaging in carotid angioplasty and stenting with protection by the reversed carotid arterial flow. AJNR Am J Neuroradiol. 2006;27:753–758
  28. Cremonesi A, Manetti F, Liso A, et al. Endovascular treatment of soft carotid plaques: a single-center carotid stent experience. J Endovasc Ther. 2006;13:190–195
  29. Yadav JS. New insights into improving acute and long-term outcomes of carotid stenting. J Am Coll Cardiol. 2006;47:2397–2398
  30. Ahmadi R, Schillinger M, Lang W, et al. Carotid artery stenting in older patients: is age a risk factor for poor outcome?. J Endovasc Ther. 2002;9:559–565
  31. Qureshi AI, Luft AR, Janardhan V, et al. Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. Stroke. 2000;31:376–382
  32. Lam RC, Lin SC, DeRubertis B, et al. The impact of increasing age on anatomic factors affecting carotid angioplasty and stenting. J Vasc Surg. 2007;45:875–880
  33. Hobson RW, Howard VJ, Robin GS, et al. Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg. 2004;40:1106–1111
  34. Kastrup A, Groschel K, Schulz JB, et al. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting. Stroke. 2005;36:787–791
  35. Alamowithc S, Eliasziw M, Algra A, et al. Risk, causes, and prevention of ischemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet. 2001;357:1154–1160
  36. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet. 2004;363:915–924
  37. The SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomized non-inferiority trial. Lancet. 2006;368:1239–1247
  38. Saam T, Hatsukami TS, Takaya N, et al. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment. Radiology. 2007;244:64–77
  39. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation. 2003;108:1664–1672
  40. Takaya N, Yuan C, Chu B, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI – initial results. Stroke. 2006;37:818–823
  41. Altaf N, MacSweeney ST, Gladman J, et al. Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with high-grade carotid stenosis. Stroke. 2007;38:1633–1635
  42. Saam T, Cai J, Ma L, et al. Comparison of symptomatic and asymptomatic atherosclerotic carotid plaque features with in vivo MR imaging. Radiology. 2006;240:464–472
  43. Hart JP, Petter P, Verbist J, et al. Do device characteristics impact outcome in carotid artery stenting?. J Vasc Surg. 2006;44:725–730
  44. Taylor AJ, Kent SM, Flaherty PJ, et al. ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002;106:2055–2060
  45. Crisby M, Nordon-Fredriksson G, Shah PK, et al. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques (Implications for plaque stabilization). Circulation. 2001;103:926–933
  46. McGirt M, Perler B, Brooke B, et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005;42:829–836
  47. Gröschel K, Ernemann U, Schulz JB, et al. Statin therapy at carotid angioplasty and stent placement: effect on procedure-related stroke, myocardial infarction, and death. Radiology. 2006;240:145–151
  48. Matsen SL, Chang DC, Perler BA, et al. Trends in the in-hospital stroke rate following carotid endarterectomy in California and Maryland. J Vasc Surg. 2006;44:488–495
  49. Kragsterman B, Pärsson H, Lindback J, et al. Outcomes of carotid endarterectomy for asymptomatic stenosis in Sweden are improving: results from a population-based registry. J Vasc Surg. 2006;44:79–85

 None of the authors have identified a conflict of interest.

PII: S1051-0443(08)00902-0

doi: 10.1016/j.jvir.2008.10.008

Journal of Vascular and Interventional Radiology
Volume 20, Issue 1 , Pages 9-16 , January 2009

Article Tools

* Image Usage & Resolution